Table 3 Origins of ovarian tumor samples studied, with results. All data are from the TCGA database. Note that sample sizes are too small for precise prevalence estimates by province or state. Many of those apparent differences may reflect random sampling error
Source Institution | Province or State | # of cases | # positive cases | % positive |
|---|---|---|---|---|
British Columbia Cancer Agency | British Columbia | 11 | 1 | 9.1% |
Gynecologic Oncology Group | California | 24 | 2 | 8.3% |
Duke University Medical Center | North Carolina | 35 | 2 | 5.7% |
University of Pittsburgh | Pennsylvania | 41 | 0 | 0.0% |
Mayo Clinic - Rochester | Minnesota | 42 | 1 | 2.4% |
Roswell Park Cancer Institute | New York | 7 | 0 | 0.0% |
Fox Chase Cancer Center | Pennsylvania | 8 | 0 | 0.0% |
Washington University School of Medicine | Missouri | 90 | 0 | 0.0% |
MD Anderson Cancer Center | Texas | 9 | 0 | 0.0% |
Harvard Medical School | Massachusetts | 10 | 0 | 0.0% |
Cedars-Sinai Medical Center | California | 27 | 0 | 0.0% |
UC San Francisco | California | 22 | 0 | 0.0% |
Memorial Sloan-Kettering Cancer center | New York | 72 | 0 | 0.0% |
International Genomics Consortium | Arizona | 7 | 0 | 0.0% |
Total | all sites | 405 | 6 | 1.5% |
